National IT infrastructure in operation to share genomics data across healthcare regions in Sweden

7 December, 2022 | News

Genomics data from healthcare can now be shared across Sweden via the National Genomics Platform. This following the signing of agreements between Genomic Medicine Sweden´s (GMS) fourteen partnering regions and universities. Thus far, this is being done within...

GMS signs agreement with Swedish Life Science industry to strengthen collaboration in precision medicine

13 October, 2022 | News

Genomic Medicine Sweden, GMS, has entered into an agreement with the Swedish Life Science sector’s trade associations to promote industry collaboration. The aim is to jointly strengthen national conditions for precision medicine. “For GMS, this agreement...

The GMS560 gene panel guides cancer patients to personalised treatment and participation in clinical studies

28 September, 2022 | News

Genomic Medicine Sweden (GMS) has developed a broad gene panel for solid tumours that facilitates detailed diagnostics for current and next generation targeted therapies. The new gene panel will be implemented in routine healthcare during the autumn. As precision...

Successful implementation of precision medicine at a national level

19 September, 2022 | News

In Sweden, the key to the successful implementation of precision medicine in healthcare has been the bottom-up approach where academia and healthcare have joined forces to build a national infrastructure. 42 authors from the Clinical Genomics platform at SciLifeLab...

Genomic Medicine Sweden and Danish National Genome Center in partnership to advance precision medicine

29 April, 2022 | Press release

Genomic Medicine Sweden and the Danish National Genome Center has signed an agreement with the aim to advance genomics and precision medicine and its implementation in healthcare. The joint partnership will focus on the development and implementation of innovative...